DK1296935T3 - Fremgangsmåde til fremstilling af substituerede octanoylamider - Google Patents

Fremgangsmåde til fremstilling af substituerede octanoylamider

Info

Publication number
DK1296935T3
DK1296935T3 DK01940047T DK01940047T DK1296935T3 DK 1296935 T3 DK1296935 T3 DK 1296935T3 DK 01940047 T DK01940047 T DK 01940047T DK 01940047 T DK01940047 T DK 01940047T DK 1296935 T3 DK1296935 T3 DK 1296935T3
Authority
DK
Denmark
Prior art keywords
octanoylamides
substituted
preparation
substituted octanoylamides
Prior art date
Application number
DK01940047T
Other languages
English (en)
Inventor
Peter Herold
Stefan Stutz
Felix Spindler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1296935T3 publication Critical patent/DK1296935T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
DK01940047T 2000-07-05 2001-06-26 Fremgangsmåde til fremstilling af substituerede octanoylamider DK1296935T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH13292000 2000-07-05
CH24502000 2000-12-15
PCT/CH2001/000399 WO2002002508A1 (en) 2000-07-05 2001-06-26 Process for the preparation of substituted octanoyl amides

Publications (1)

Publication Number Publication Date
DK1296935T3 true DK1296935T3 (da) 2009-06-22

Family

ID=25738979

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01940047T DK1296935T3 (da) 2000-07-05 2001-06-26 Fremgangsmåde til fremstilling af substituerede octanoylamider

Country Status (24)

Country Link
US (1) US6730798B2 (da)
EP (1) EP1296935B1 (da)
JP (1) JP4900755B2 (da)
KR (1) KR100690471B1 (da)
CN (1) CN100482636C (da)
AR (1) AR029564A1 (da)
AT (1) ATE426592T1 (da)
AU (2) AU7376301A (da)
BR (1) BR0112362B1 (da)
CA (1) CA2414847C (da)
CY (1) CY1109110T1 (da)
DE (1) DE60138099D1 (da)
DK (1) DK1296935T3 (da)
ES (1) ES2322547T3 (da)
HK (1) HK1093201A1 (da)
HU (1) HU228526B1 (da)
IL (4) IL153717A0 (da)
MX (1) MXPA02012628A (da)
NO (1) NO328105B1 (da)
NZ (1) NZ523088A (da)
PL (1) PL212898B1 (da)
PT (1) PT1296935E (da)
TW (1) TWI289551B (da)
WO (1) WO2002002508A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003103653A1 (en) * 2002-06-11 2003-12-18 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease using aryl alkanoic acid amides
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds
GB0511686D0 (en) 2005-06-08 2005-07-13 Novartis Ag Organic compounds
CN101218218B (zh) * 2005-07-11 2012-10-10 诺瓦提斯公司 新型焦儿茶酚衍生物
GB0519764D0 (en) 2005-09-28 2005-11-09 Novartis Ag Organic compounds
GB2431645A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431649A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
DE102005052195A1 (de) 2005-10-28 2007-05-03 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von chiralen Octensäurederivaten
GB0605688D0 (en) 2006-03-21 2006-05-03 Novartis Ag Organic compounds
RU2466982C2 (ru) * 2006-11-07 2012-11-20 Новартис Аг Кристаллические формы гемифумарата алискирена
CA2665073A1 (en) * 2006-11-09 2008-05-15 Novartis Ag Salt of aliskiren with orotic acid
EP1958666A1 (en) 2007-02-13 2008-08-20 Speedel Experimenta AG Heterocyclic-substituted alkanamides as therapeutic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
JP2011503185A (ja) 2007-11-13 2011-01-27 テバ ファーマシューティカル インダストリーズ リミティド ヘミフマル酸アリスキレンの多形形態及びその調製プロセス
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
CN102036948A (zh) * 2008-05-23 2011-04-27 特瓦制药工业有限公司 阿利吉仑单富马酸盐及其制备方法
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren
WO2010091277A2 (en) 2009-02-05 2010-08-12 Teva Pharmaceutical Industries Ltd. Solid state forms of aliskiren compounds
EP2393489B1 (en) 2009-02-05 2014-10-08 Krka, tovarna zdravil, d.d., Novo mesto Moisture-activated granulation process
US20120220663A1 (en) 2009-09-03 2012-08-30 Teva Pharmaceuticals Usa, Inc. Solid forms of aliskiren hemifumarate and processes for preparation thereof
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
US20110113995A1 (en) * 2009-11-13 2011-05-19 Lindsay Corporation Method and apparatus for planting and irrigation
WO2011148392A1 (en) * 2010-05-28 2011-12-01 Msn Laboratories Limited Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof
ES2528701T3 (es) 2010-10-19 2015-02-11 Mylan Laboratories Limited Síntesis de Aliskiren
ITMI20110893A1 (it) * 2011-05-19 2012-11-20 Chemelectiva S R L Processi ed intermedi per la sintesi di aliskiren
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
WO2013118138A1 (en) 2011-12-13 2013-08-15 Laboratories Ltd Mylan Novel process for the preparation of renin inhibitors
US9090537B2 (en) 2012-02-17 2015-07-28 Mylan Laboratories Limited Process for the preparation of aliskiren
WO2013124868A2 (en) 2012-02-21 2013-08-29 Mylan Laboratories Limited Solid form of aliskiren intermediate
WO2013144979A1 (en) 2012-03-28 2013-10-03 Maylan Laboratories Ltd Process for the preparation of aliskiren
WO2013171767A1 (en) 2012-05-18 2013-11-21 Mylan Laboratories Limited An improved process for the preparation of aliskiren
CN106220528B (zh) * 2014-02-28 2018-05-08 华润双鹤药业股份有限公司 阿利吉仑的4-位差向异构体、其制备方法及用途
CN106146339B (zh) * 2015-04-23 2018-02-23 华润双鹤药业股份有限公司 阿利吉仑的5‑位差向异构体、其制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492799A (en) * 1979-07-02 1985-01-08 Union Carbide Corporation Halo-4-alkenoic acids and their use as pesticidal intermediates
FR2666757B1 (fr) * 1990-09-14 1992-12-18 Usinor Sacilor Virole pour cylindre de coulee continue des metaux, notamment de l'acier, entre cylindres ou sur un cylindre.
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
ATE174237T1 (de) * 1994-07-18 1998-12-15 Siemens Ag Giesswalzen-verschleissschutzschicht
AU7418198A (en) * 1997-05-23 1998-12-11 Voest-Alpine Industrieanlagenbau Gmbh Casting cylinder for thin-band continuous casting installation
JP4922521B2 (ja) * 1999-07-29 2012-04-25 シュペーデル・ファルマ・アーゲー Ｎ−置換２，７−ジアルキル−４−ヒドロキシ−５−アミノ−８−アリール−オクタノイルアミドの製造

Also Published As

Publication number Publication date
DE60138099D1 (de) 2009-05-07
ATE426592T1 (de) 2009-04-15
KR20030017543A (ko) 2003-03-03
IL187795A0 (en) 2008-03-20
CA2414847A1 (en) 2002-01-10
NO328105B1 (no) 2009-12-07
JP2004502667A (ja) 2004-01-29
IL153717A (en) 2008-11-03
CA2414847C (en) 2009-06-16
AU7376301A (en) 2002-01-14
IL153717A0 (en) 2003-07-06
HUP0301463A2 (hu) 2003-09-29
AU2001273763B2 (en) 2006-07-13
KR100690471B1 (ko) 2007-03-09
AR029564A1 (es) 2003-07-02
MXPA02012628A (es) 2004-09-10
PL358887A1 (en) 2004-08-23
IL187796A (en) 2009-05-04
CN100482636C (zh) 2009-04-29
EP1296935B1 (en) 2009-03-25
IL187796A0 (en) 2008-03-20
US20030149303A1 (en) 2003-08-07
CY1109110T1 (el) 2014-07-02
BR0112362B1 (pt) 2013-12-31
EP1296935A1 (en) 2003-04-02
PT1296935E (pt) 2009-05-15
IL187795A (en) 2009-05-04
HU228526B1 (hu) 2013-03-28
NZ523088A (en) 2004-06-25
ES2322547T3 (es) 2009-06-23
CN1440381A (zh) 2003-09-03
WO2002002508A1 (en) 2002-01-10
PL212898B1 (pl) 2012-12-31
BR0112362A (pt) 2003-05-13
JP4900755B2 (ja) 2012-03-21
HUP0301463A3 (en) 2008-03-28
US6730798B2 (en) 2004-05-04
TWI289551B (en) 2007-11-11
HK1093201A1 (en) 2007-02-23
NO20030012D0 (no) 2003-01-02
NO20030012L (no) 2003-03-03

Similar Documents

Publication Publication Date Title
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1173431T4 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1309582T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1181272T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1181713T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
DK1392711T3 (da) Fremgangsmåde til fremstilling af xylose
DK1401845T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin